Press Releases

“The FDA is failing to ensure vitally important pharmaceuticals remain on pharmacy shelves.” WASHINGTON—House Committee on Oversight and Accountability Chairman James Comer (R-Ky.) and Subcommittee on Health Care and Financial Services Chairwoman Lisa McClain (R-Mich.) today are calling on the U.S. Food and Drug Administration (FDA) to provide information to understand the FDA’s response to a growing number of critical drug shortages delaying and prohibiting ...

WASHINGTON—The Subcommittee on Government Operations and the Federal Workforce and Subcommittee on Health Care and Financial Services held a joint hearing titled “Oversight of the Internal Revenue Service” with Internal Revenue Service Commissioner Danny Werfel to examine the Internal Revenue Service’s plans to utilize an additional $80 billion in long-term funding allocated by ...

WASHINGTON—Subcommittee on Health Care and Financial Services Chairwoman Lisa McClain (R-Mich.) today opened a joint subcommittee hearing titled “Oversight of the Internal Revenue Service” by warning how while the IRS struggles to complete its basic job and taxpayer services, congressional Democrats’ Inflation Reduction Act doled out $80 billion to the IRS to hire more agents and increase ...

Committee is considering compulsory process following inadequate response from FEMA WASHINGTON—House Committee on Oversight and Accountability Chairman James Comer (R-Ky.) and Majority Leader Steve Scalise (R-La.) are threatening the compulsory process to obtain compliance with a May 1, 2023, oversight request for documents and information related to the Federal Emergency Management Agency’s (FEMA) National Flood Insurance Program (NFIP). In the new letter to FEMA ...

WASHINGTON—The Subcommittee on Health Care and Financial Services held a hearing today titled “The Inflation Reduction Act: A Year in Review” to discuss how one year removed from Democrats’ so-called Inflation Reduction Act (IRA), it’s clear Americans are not benefiting from IRA policies. When the American people needed economic relief most, the ...

WASHINGTON—Subcommittee on Health Care and Financial Services Chair Lisa McClain (R-Mich.) opened today’s subcommittee hearing titled “The Inflation Reduction Act: A Year in Review” by noting how one year removed from Democrats’ so-called Inflation Reduction Act (IRA), Americans are worse off. Chairwoman McClain outlined how instead of lowering ...

WASHINGTON—Subcommittee on Health Care and Financial Services Chairwoman Lisa (R-Mich.) today announced a hearing titled “The Inflation Reduction Act: A Year in Review” to examine the impacts of President Biden’s Inflation Reduction Act (IRA) on the economy, American taxpayers, and small businesses. The IRA hiked taxes on businesses, mandated price controls on drugs, devoted $80 billion ...

“The lack of action has cast a shadow over the industry” WASHINGTON—The Subcommittee on Health Care and Financial Services yesterday held a hearing titled “Hemp in the Modern World: The Yearslong Wait for FDA Action” to examine the failures of the Food and Drug Administration (FDA) to regulate CBD and hemp-derived products. Despite the 2018 ...

WASHINGTON—Subcommittee on Health Care and Financial Services Chairwoman Lisa McClain (R-Mich.) opened today’s hearing titled “Hemp in the Modern World: The Yearslong Wait for FDA Action” by discussing the failures of the Food and Drug Administration (FDA) to regulate hemp products. Instead, the FDA is asking Congress for more regulatory authority which has led ...

WASHINGTON—Subcommittee on Health Care and Financial Services Chairwoman Lisa McClain (R-Mich.) today announced a hearing titled “Hemp in the Modern World: The Yearslong Wait for FDA Action” to examine the Food and Drug Administration (FDA)’s failure to regulate hemp-derived and cannabidiol (CBD) products under existing authorities for years. “The FDA has failed for too long to do its job to ensure the safety of legalized hemp-derived products. Without these regulations, ...